Search Results - laxman gangwani

HOME SEARCH RSS
1 Results Sort By:
Use of JNK Signaling and JNK Inhibitors for the Treatment of Spinal Muscular Atrophy
Current State of the Art: SMA is a devastating neurodegenerative disorder with progressive muscle weakness and loss of motor control due to the loss of neurons in the spinal cord. SMA affects approximately 4 out of every 100,000 people. Children born with SMA Type I, die within 2 years of birth. Those diagnosed with Type II and III can live ...
Published: 7/26/2011   |   Inventor(s): Laxman Gangwani
Keywords(s): Muscular Atrophy, Spinal, Therapeutics
Category(s): Therapeutics
© 2019. All Rights Reserved. Powered by Inteum